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Abstract
Background: Vinyl chloride (VC), an environmental contaminant, is directly hepatotoxic at high
concentrations. However, our group has recently demonstrated that VC and the VC metabolite
chloroethanol (CE), at concentrations that are not considered hepatotoxic, enhanced liver injury
caused by high-fat diet (HFD). These data therefore suggest that the impact of VC exposure on
hepatic tissue may be enhanced with underlying metabolic syndrome and/or liver injury. It is
known that there is an axis between adipose and hepatic tissue in non-alcoholic fatty liver
disease (NAFLD), with the former impacting pathology in the hepatic tissue via release of proinflammatory cytokines and/or lipolysis. The current study investigated the impact of CE on
epidydimal white adipose tissue (WAT) inflammation and lipolysis.
Methods: Mice were administered CE (or vehicle) once, 10 weeks after being fed a diet high in
saturated fatty acids (HFD: 42% milk fat), or a low fat control diet (LFD: 13% milk fat). Animals
were sacrificed 0-24 hours after CE exposure. Plasma, liver and WAT samples were harvested
for determination of liver damage, changes in energy metabolism, endoplasmic reticulum (ER)
stress, and inflammation.
Results: Hepatic steatosis and inflammation caused by HFD was significantly enhanced by CE.
Moreover, while HFD significantly increased the size of epididymal fat pads, this increase was
enhanced by CE. Adipocyte lipid droplets relative size was also increased in the HFD/CE
group; which correlated with the increased expression of lipid-associated proteins (e.g., perilipin;
PLINs). Although adipose tissue of LFD-fed mice was not affected by CE, CE significantly
enhanced HFD-increased indices of WAT inflammation, and ER stress. It has been shown that
hepatic-derived fibroblast growth factor 21 (FGF21) is a major modulator of WAT lipolysis and is
hypothesized to thereby regulate hepatic steatosis [1, 2]. Here we demonstrate that circulating
levels of FGF21 are significantly increased by CE in animals fed a HFD, suggesting a possible
role for WAT-mediated hepatic steatosis due to changes in WAT lipolysis.
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Conclusion: Chloroethanol (as a VC surrogate) can enhance local inflammation and alter lipid
metabolism in WAT in experimental obesity. Taken together these data support the hypothesis
that environmental toxicant exposure can exacerbate the severity of NAFLD or non-alcoholic
steatohepatitis (NASH) and supports a role of the liver-adipose axis in this process.

Keywords: PVC, TASH, plastic, hepatotoxicity, saturated fat, metabolic syndrome
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Introduction
Vinyl chloride is an organochlorine monomer used in industry to create the polymer,
polyvinyl chloride (PVC), and its production was recently estimated at 27 million metric tons
annually [3]. VC exposure occurs near Superfund sites and landfills, where it exists as a solvent
degradation product [4] and in the chemical industry, especially in the United States, Europe
and China [4, 5]. While significant concentrations of VC have been found in the ambient air
surrounding manufacturing complexes, contaminated groundwater in areas surrounding
production sites is the main environmental exposure risk. Because VC is highly volatile, VC can
migrate through soil and foundations to enter basements or living spaces in homes located
above contaminated groundwater. Owing to its widespread presence in EPA superfund sites
and its known potential human risk, VC is ranked #4 on the ATSDR Hazardous Substance
Priority List [6].

VC is a known human hepatotoxicant that causes several benign and malignant
diseases, including hepatocellular carcinoma (HCC), hemangiosarcoma and toxicant associated
steatohepatitis [7]. These direct effects of VC exposure are hypothesized to be caused only by
high occupational exposures and have limited relevance with existing VC safety regulations.
However, the effect of low environmental VC exposure in contrast to high occupational VC
exposures has not been studied. Importantly, other factors that may increase hepatotoxicity
need to be considered when determining the impact of low exposure. In this context, it is critical
to determine the effect of underlying disorders or other insults that may modify risk. Importantly,
our group has shown recently that sub-hepatotoxic concentrations of VC metabolite
chloroethanol (CE) can enhance liver injury and inflammation caused by other factors, such as
high fat diet or lipopolysaccharide [8, 9].
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Obesity is a significant problem in the US and worldwide. The prevalence of obesity
related morbidity such as non-alcoholic fatty liver disease (NAFLD) or non-alcoholic
steatohepatitis (NASH) has increased. It is proposed that approximately ¼ of the US adult
population have abnormal liver enzymes - a surrogate marker for NAFLD/NASH. Indeed, NASH
has been projected to be the leading cause of liver transplantation in the United States by 2020
[10]. NAFLD progression is enhanced in patients with features of the metabolic syndrome, such
as insulin resistance, type II diabetes, and dyslipidemia [11]. Expansion of adipocytes, during
the development of obesity and the metabolic syndrome, results in a chronic inflammatory state
of the white adipose tissue (WAT). Adipose tissue specific cytokines (adipokines) are further
responsible for the inflammatory environment associated with central obesity and its
complications, including NAFLD and NASH [12, 13].
While we have shown that VC metabolites can exacerbate hepatic inflammation and
dysregulate hepatic energy metabolism [8, 9], no studies to date have investigated the effect of
these metabolites on adipose tissue. The current study was therefore designed to address the
role of WAT inflammation in the progression of liver injury caused by CE with a background of
obesity.
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Methods
Animals and Treatments
Eighty male C57BL/6J mice, 8 weeks old, from Jackson Laboratory (Bar Harbor, ME)
were housed in a pathogen-free barrier facility accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care, and procedures were approved by the local
Institutional Animal Care and Use Committee. As previously described [9], mice were fed a low
fat control or a high fat diet (see below) for 10 weeks. At the end of the 10 weeks 20 animals
were administered chloroethanol (CE; 50 mg/kg i.g.) and 20 animals were administered vehicle
(water) 24 hours prior to sacrifice. Previous studies by our lab have demonstrated that this
concentration of CE does not directly cause liver damage [8, 9]. At sacrifice, animals were
anesthetized with ketamine/xylazine (100/15 mg/kg, i.m.). Body weights were measured. Blood
was collected from the vena cava just prior to sacrifice (exsanguination), and citrated plasma
was stored at -80°C for further analysis. Organs were weighed. Portions of tissues were snapfrozen in liquid nitrogen, embedded in frozen specimen medium (Sakura Finetek, Torrance,
CA), or were fixed in 10% neutral buffered formalin.
Low fat diet (LFD): [13% calories as fat; Casein 195.0 g/kg, DL-Methionine 3.0 g/kg,
Sucrose 120.0 g/kg, Corn Starch 432.89 g/kg, Maltodextrin 100.0 g/kg, Anhydrous Milkfat 37.2
g/kg, Soybean Oil 12.8 g/kg, Cellulose 50.0 g/kg, Mineral Mix, AIN-76 (170915) 35.0 g/kg,
Calcium Carbonate 4.0 g/kg, Vitamin Mix, Teklad (40060) 10.0 g/kg, Ethoxyquin, antioxidant
0.01 g/kg; (Harlan Laboratories, Madison, WI)].
High fat diet (HFD): [42% calories as fat; Casein 195.0 g/kg, DL-Methionine 3.0 g/kg,
Sucrose 341.31 g/kg, Corn Starch 75.0 g/kg, Maltodextrin 75.0 g/kg, Anhydrous Milkfat 210.0
g/kg, Cholesterol 1.5 g/kg, Cellulose 50.0 g/kg, Mineral Mix, AIN-76 (170915) 35.0 g/kg,
Calcium Carbonate 4.0 g/kg, Vitamin Mix, Teklad (40060) 10.0 g/kg, Ethoxyquin, antioxidant
0.04 g/kg; (Harlan Laboratories, Madison, WI)].
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Biochemical Analyses, Histology and Immunohistochemistry
Plasma transaminases (ALT and AST) were determined using standard kits (Thermo
Fisher Scientific, Middletown, VA). Paraffin embedded adipose sections were stained with
hematoxylin & eosin (H&E) and neutrophil accumulation was assessed by chloroacetate
esterase stain (CAE; Sigma, St. Louis MO). CAE-positive cells were counted using Metamorph
Image Analysis Software (Molecular Devices, Sunnyvale, CA) and are expressed as positive
cells per microscope field. Paraffin embedded adipose sections were also stained with
Perilipin/TUNEL to asses apoptotic adipocytes. Lipids were extracted from snap-frozen samples
as described previously [14, 15]. Hepatic and plasma lipids were determined using standard
clinical chemistry reagents for cholesterol, and triglycerides (Infinity, Thermo Fisher Scientific,
Middletown, VA).

Immunoblots
Tissue samples were homogenized in RIPA buffer [16] containing protease and
phosphatase inhibitor cocktails (Sigma, St. Louis, MO). Samples were loaded onto SDSpolyacrylamide gels (Invitrogen, Thermo Fisher Scientific, Grand Island, NY), followed by
electrophoresis and Western blotting onto PVDF membranes (Hybond P, GE Healthcare BioSciences, Pittsburgh, PA). Primary polyclonal antibodies for mouse heat shock protein 90
(HSP90), activating transcription factor 3 (ATF-3), and CCAAT-enhancer-binding protein
homologous protein (CHOP) were used and compared to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (Cell Signaling Technology; Beverly, MA). Densitometric analysis
was performed using UN-SCAN-IT gel (Silk Scientific Inc., Orem, UT) software.

RNA Isolation and Real-Time RT-PCR
RNA was extracted immediately following sacrifice from fresh tissue samples using RNA
Stat60 and chloroform. Real-time RT-PCR was performed using a StepOne real time PCR
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system (Thermo Fisher Scientific, Grand Island, NY). Primers and probes were ordered as
commercially available kits (Thermo Fisher Scientific, Grand Island, NY). The comparative CT
method was used to determine fold differences between the target genes and an endogenous
reference (18S).

Statistical Analyses
Results are reported as means ± SEM (n = 4-7) and were analyzed using SigmaPlot 11.0
(Systat Software, Inc.; San Jose, CA). ANOVA with Bonferroni’s post-hoc test (for parametric
data) or Mann-Whitney Rank Sum test (for nonparametric data) were used for the determination
of statistical significance among treatment groups, as appropriate. Student’s t-test and Fisher’s
exact test were used to determine statistical significance between subject groups. A p value <
0.05 was selected before the study as the level of significance.
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Results
Effect of CE on liver and fat weight changes caused by HFD
At sacrifice, liver weights (LW), body weights (BW) and fat weights (FW) were
measured. Both LW:BW and FW:BW ratios were determined (Figure 1b). CE caused no
changes in either liver weight or fat weight in the LFD group. As observed previously, HFD
increased both LW:BW and FW:BW ratios. CE did not affect the LW:BW ratio, but it did
enhance the increase in the FW:BW ratio by HFD.

CE enhances liver injury caused by HFD
Figure 1a demonstrates representative photomicrographs depicting liver pathology
(H&E) in tissues harvested 24 h after CE exposure. While CE did not cause any pathologic
changes in the absence of a HFD, it did significantly enhance inflammation in the presence of a
HFD. Moreover, CE also significantly increased fat accumulation in this group. Consistent with
these results, plasma levels of transaminases were within normal levels for both, LFD and
LFD+CE (Table 1). However, plasma transaminase levels were significantly elevated in the HFD
group, and further exacerbated by CE.
Circulating and hepatic lipid concentrations were measured (Table 1). CE did not
significantly affect triglycerides and cholesterol levels in mice fed a LFD. In the presence of
HFD, CE significantly increased circulating triglyceride levels. In addition, CE exacerbated the
increase in circulating cholesterol levels caused by HFD. A similar effect was observed in
hepatic triglyceride and cholesterol levels; both cholesterol and triglyceride levels were
increased in high fat diet groups when compared to low fat controls. However, CE significantly
elevated triglyceride levels in the HFD diet group.
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Effects of CE on changes to the WAT caused by HFD
Figure 2a shows representative photomicrographs depicting adipose pathology (H&E),
inflammation (F4/80), and the presence of cytoplasmic lipid vesicles (Perilipin) 24 h after CE. No
pathological changes were observed for LFD + CE (H&E). However, CE significantly increased
the number of infiltrating macrophages (F4/80) in the HFD group. Positive staining for apoptotic
adipocytes was significantly increased in the HFD group, while CE had no effect (Perilipin).
Interestingly, neutrophil accumulation (CAE positive cells, Figure 2d) was increased in the
presence of CE in the LFD group only.

As demonstrated previously (e.g.[17]), the adipocyte size (Figure 2b) was significantly increased
in the HFD group. CE, while having no effect on adipocyte size in the LFD group, significantly
enhanced this effect. Additionally, expression of genes regulating lipid associated proteins in
WAT was determined (Figure 2c). WAT mRNA expression for Plin5 and Plin2 was not affected
by CE in mice fed LFD. HFD alone increased Plin5 mRNA expression in WAT, which was
significantly enhanced by CE. While Plin2 mRNA expression levels was not increased by HFD
only, CE induced expression of Plin2 in this group.

Changes of the WAT inflammatory profile caused by HFD and CE
The effects of CE on WAT mRNA expression of key inflammatory markers (F4/80,
Cd11c, Cd68, and Ly6g) was determined (Figure 3a). CE caused changes in expression of
F4/80, Cd68, and Ly6g in the control group. However, Cd11c expression was significantly
increased by CE alone. While CE increased expression of F4/80, Cd11c, Cd68 caused by HFD,
expression of Ly6g was unchanged.
In addition, mRNA expression of cytokines was measured in WAT tissue (Figure 3b).
While having no effect in the absence of HFD, expression of all genes, Il-10, Pai-1, Mip-1 and
Mip2, was significantly increased with the combination of CE and HFD.
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Effects of CE on endoplasmic reticulum stress caused by HFD
ER stress induces lipolysis in WAT, therefore contributing to increases in circulating
FFAs and fatty infiltration into other organs, such as liver [18]. Therefore, markers of ER stress
were examined (Figure 4). While CE significantly increased expression of ER stress markers
Chop and Atf3 in the LFD group (Figure 4a), no changes were observed in the HFD groups. On
protein level, CE had no effect in the presence of LFD, but enhanced ATF3 protein (Figure 4b).

Changes in adipokine expression caused by CE.
It is well known that there is a cross-talk between the liver and WAT via adipokines, such
as leptin, adiponectin, and FGF21 [19]. Therefore, circulating protein and WAT mRNA
expression levels were measured in order to determine the possible mechanism by which CE
enhances NAFLD through changes of the WAT (Figure 5). Here, we show that circulating levels
of leptin were significantly increased by HFD. Additionally, CE in combination with HFD
significantly increased Lep mRNA expression and circulating leptin levels. In contrast, a
significant decrease in adiponectin was observed for both mRNA expression and circulating
plasma levels. An increasing trend for Fgf21 mRNA expression was observed; however, a
significant increase in plasma proteins was observed for FGF21. FGF21 is a major modulator of
WAT lipolysis and is hypothesized to thereby regulate hepatic steatosis.
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Discussion
In the past few years, the impact of moderate/low chronic exposures in contrast to
high/occupational exposures has been a major topic of investigation in environmental research.
Multiple aspects, such as a high fat diet may contribute to the final phenotype. It is therefore
critical to examine the impact these aspects may have in modifying risk for developing diseases.
Today, obesity affects the US population more than any other underlying disorder and is
therefore argued to be one of the most widespread. The risk for health complications, including
diabetes, cancer and cardiovascular disease may be enhanced by obesity. In the United States
and other developed countries, a parallel increase is observed between obesity, NAFLD and
other metabolic disorders [20]. However, other risk-modifying conditions, such as other
environmental or genetic factors, contribute to the risk of developing these diseases.
Furthermore, to this day it is poorly understood what impact obesity has on the risk of
developing metabolic disorders caused by other events, such as environmental exposure.
We have previously shown in a proof-of-concept study that the VC metabolite CE
sensitizes the liver to injury caused by HFD. Markers of inflammation, ER stress, and
inflammasome activation, were significantly increased by CE in animals fed a HFD [9]. The
purpose of the current study was to investigate the effect of CE on WAT and examine the
potential contribution of the liver - adipose axis in the progression of liver injury caused by
CE+HFD. Pathologic changes to the WAT have been shown to be an important event, early in
the development of the metabolic complications of obesity. These changes are mainly
characterized by pro-inflammatory macrophage infiltration resulting in an increased production
of cytokines, chemokines, and/or reactive oxygen species that induce insulin resistance and
fatty liver [21]. Indeed, CE significantly increased WAT inflammation and the subsequent
inflammatory response. Furthermore, WAT inflammation is considered to be an important
initiator of the inflammatory response brought on by obesity [22]. Cytokines and fatty acids are
released into circulation by adipose tissue, therefore leading to hepatic insulin resistance and
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further liver injury [22]. An increase in apoptotic adipocytes with a HFD (Figure 2a) has been
shown to cause insulin resistance and hepatic steatosis [22]. Increases in cytokine and
inflammatory mRNA expression in WAT (Figures 3a and 3b), macrophage infiltration (Figure
2a), modified adipokine expression (Figures 5a and 5b) and an increase in apoptotic adipocytes
(Figure 2a) provides evidence that WAT injury leads to subsequent metabolic disruptions in the
liver. Therefore, an axis between the liver and WAT, where WAT contributes to the progression
of liver injury, in a HFD + CE model is supported.
An increase in WAT weight and enlargement of adipocyte size are associated with
enhanced lipolysis [23]. Lipolysis of WAT triglyceride stores results in the release of fatty acids
into the vasculature for use by other organs as energy substrates. Under normal conditions,
lipolysis is a tightly regulated process. However, a dysregulation of lipolysis may result in
elevated levels of circulating lipids that contribute to hepatic steatosis, eventually leading to
insulin resistance [24]. In this study, CE significantly increased overall fat weight (Figure 1b)
and adipocyte size (Figure 2b). In addition, hepatic triglyceride levels were increased in this
study (Table 1). In line with the increased fat weight (Figure 1b) and adipocyte size (Figure 2b);
lipid-associated proteins 2 and 5 (PLIN2 and PLIN5) expression in WAT was enhanced by CE
(Figure 2c). PLIN5 in particular has been shown to play multiple metabolic roles and is involved
in adaptation to environmental stressors. For example, increased expression of Plin5 may be
an adaptive response to reduce lipolysis [25, 26].
Another important factor that has been shown to induce lipolysis in WAT is ER stress
[27, 28]. Moreover, upon ER stress, WAT interacts with the liver through upregulation of
inflammatory and metabolic mechanisms, therefore leading to profound hepatic alterations [27,
28]. Here, markers for ER stress were examined. Indeed, here CE did cause changes to mRNA
and protein expression of markers of ER stress (Figure 4). While there is a pattern of changes
between mRNA expression and protein, this can be attributed to temporal effects as mRNA
expression and protein expression are temporally distant processes. Moreover, other factors
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such as duration of the experiment, or circadian rhythm may influence expression level
differences [29]. However, our results support the hypothesis that ER stress may at least play a
partial role in the mechanism of injury in this model.
As mentioned previously, WAT inflammation is associated with a modification in the
secretion of cytokines specific to the adipose tissue (adipokines). Importantly, dysregulation of
adipokine levels during WAT inflammation may contribute to insulin resistance, hepatic injury,
steatosis, and inflammation [30, 31]. Here, adipokine expression was significantly affected by
CE exposure. High circulating leptin levels may contribute to hepatic steatosis by promoting
insulin resistance and by altering insulin signaling pathways in hepatocytes [23]. In addition, it
has been suggested that leptin may also be proinflammatory as leptin is responsible for
promoting the generation of proinflammatory cytokines [23]. The increase in circulating leptin in
this model (Figure 5b) may therefore contribute to the enhanced expression of genes for proinflammatory cytokines. Adiponectin is known to be regulated in opposition of leptin. Low levels
may cause an increase in glucose production, further leading to an increase in insulin secretion
[32]. Indeed, in the current study adiponectin levels were decreased (Figure 5b).
In previous studies, it has been shown that FGF21, a polypeptide growth factor that acts
as a metabolic regulator, may control WAT lipolysis in response to different metabolic states [1].
Moreover, it has been shown that HFD increases in Fgf21 WAT mRNA expression [33]. Here,
CE further enhanced this effect (Figure 5a). While these data were not statistically significant,
this may be explained by a temporary effect of mRNA expression. Importantly, CE did
significantly increase circulating levels of FGF21 protein (Figure 5b). FGF21 has been shown to
regulate WAT lipid homeostasis. FGF21 has also been shown to play a major role in alcoholinduced adipose lipolysis and in hepatic fat accumulation in animal models of alcoholic liver
disease (ALD) [2]. Moreover, circulating FGF21 levels are significantly increased in patients
with ALD and in experimental animal models. Importantly, metabolism of VC and its metabolites
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is very similar to that of alcohol. Therefore, these data suggest that FGF21 may also be a critical
player in the mechanisms of this model.

Summary and Conclusions
The results of this study suggest that the VC metabolite, chloroethanol, enhances
inflammation, ER stress and changes to adipokine expression caused by HFD. These results
therefore support the hypothesis that changes to the WAT caused by CE and HFD contribute to
liver injury in this model. These results therefore add weight to the hypothesis that
environmental exposure to VC may exacerbate underlying liver disease through cross talk
between adipose tissue and liver.
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Table 1: CE enhances hepatic damage markers and changes in plasma and hepatic lipid
content.
ALT/AST levels were determined in plasma samples collected 24 hours after injection of CE.
Hepatic and plasma lipid contents were determined by the Piccolo Lipid Plus Reagent Disc and
Piccolo Xpress Chemistry Analyzer (Abaxis, Inc., Union City, CA) according to the
manufacturer’s instructions. a, p < 0.05 compared to the absence of HFD; b, p < 0.05 compared
to the absence of CE.
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Figure legends:
Figure 1: CE enhances lipid accumulation.
A: Representative photomicrographs of H&E stains 200x magnification are shown for liver. B:
Both LW:BW and FW:BW ratios were determined. a, p < 0.05 compared to the absence of HFD;
b

, p < 0.05 compared to the absence of CE. n=4-8.

Table 1: CE enhances hepatic damage markers and changes in plasma and hepatic lipid
content.
ALT/AST levels were determined in plasma samples collected 24 hours after injection of CE.
Hepatic and plasma lipid contents were determined by the Piccolo Lipid Plus Reagent Disc and
Piccolo Xpress Chemistry Analyzer (Abaxis, Inc., Union City, CA) according to the
manufacturer’s instructions. a, p < 0.05 compared to the absence of HFD; b, p < 0.05 compared
to the absence of CE.
Figure 2: CE increases overall WAT injury.
A: Representative photomicrographs of H&E, F4/80, and Perilipin/TUNEL stains at 200x
magnification are shown for WAT. B: Adipocyte size was determined. C: Real-Time RT-PCR
was performed to measure the expression of lipid droplet associated proteins. a, p < 0.05
compared to the absence of HFD; b, p < 0.05 compared to the absence of CE.D: CAE-positive
cells were counted using Metamorph Image Analysis Software (Molecular Devices, Sunnyvale,
CA) and are expressed as positive cells per microscope field.
Figure 3: CE alters WAT expression of inflammatory associated genes.
A: RT-PCR for genes associated with inflammatory markers. B: RT-PCR for genes associated
with cytokine expression. a, p < 0.05 compared to the absence of HFD; b, p < 0.05 compared to
the absence of CE.
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Figure 4: CE effects ER stress.
A: RT-PCR was performed for genes associated with ER stress. B: Representative Western
blots for HSP90, CHOP, and ATF-3 are shown. Densitometric analyses of proteins are also
shown. a, p < 0.05 compared to the absence of HFD; b, p < 0.05 compared to the absence of
CE.
Figure 5: CE negatively effects adipokine expression and concentrations.
A: RT-PCR for genes associated with adipokine expression in WAT was performed. B:
Circulating adipokine concentrations for FGF21, Adiponectin, and Leptin were measured in
plasma through the implementation of an ELISA. a, p < 0.05 compared to the absence of HFD; b,
p < 0.05 compared to the absence of CE. n=4-8.
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Figure 4: CE effects ER stress.
A: RT-PCR for genes associated with ER stress was performed. B: Representative Western
blots for HSP90, CHOP, and ATF-3 are shown. Densitometric analyses of proteins are also
shown. a, p < 0.05 compared to the absence of HFD; b, p < 0.05 compared to the absence of
CE.
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Figure 5: CE negatively effects adipokine expression and concentrations.
A: RT-PCR for genes associated with adipokine expression in WAT was performed. B:
Circulating adipokine concentrations for FGF21, Adiponectin, and Leptin were measured in
plasma through the implementation of an ELISA. a, p < 0.05 compared to the absence of HFD; b,
p < 0.05 compared to the absence of CE. n=4-8.
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